SAVI Scout for breast cancer surgery localization
Part of Cancer, Skin clinical trials.
This trial studies a new method (SAVI Scout) to help surgeons locate and remove breast tumors more precisely during surgery. It may reduce the need for multiple markers and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman 18 years or older.
- You have been diagnosed with breast cancer that can be seen on ultrasound, mammogram, or MRI.
- You need surgery to remove the cancer, which requires more than one marker to guide the surgeon.
- You are willing and able to have surgery at Moffitt Cancer Center.
- You are not having a mastectomy or surgery on multiple separate areas in the same breast.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a small implantable “marker” system (used to help doctors find the tumor or lymph node during breast surgery) for people with breast or lymph node areas that can’t be felt. It may help surgery planning and accuracy when the cancer can’t be easily located by touch.
This study compares two ways surgeons take “margin” samples (tissue from the edge of the tumor area) during breast-conserving surgery for early breast cancer. It uses a guidance device to help collect these samples and aims to see which approach better supports safe, effective treatment.
This trial compares two techniques for finding breast tumors that cannot be felt by hand after initial (neoadjuvant) treatment. If successful, it may make breast-conserving surgery more accurate when the tumor has become “non-palpable.”
This trial looks at different methods doctors can use to locate a breast lesion using imaging, so it can be removed accurately during breast-conserving surgery. It may help your care team choose the best localization approach for your type and location of lesion.
This trial compares two techniques for pinpointing non-touchable breast cancer during breast-conserving surgery. The study aims to see which method is more accurate and whether it leads to better surgical outcomes.
This study tests a scanner (Histolog®) that checks the edges of removed breast tissue during surgery to make sure all cancer is removed. The goal is to reduce the need for a second surgery.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.